227 related articles for article (PubMed ID: 32390003)
1. The crucial p53-dependent oncogenic role of JAB1 in osteosarcoma in vivo.
Samsa WE; Mamidi MK; Bashur LA; Elliott R; Miron A; Chen Y; Lee B; Greenfield EM; Chan R; Danielpour D; Zhou G
Oncogene; 2020 Jun; 39(23):4581-4591. PubMed ID: 32390003
[TBL] [Abstract][Full Text] [Related]
2. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX
Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252
[TBL] [Abstract][Full Text] [Related]
4. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.
Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R
J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199
[TBL] [Abstract][Full Text] [Related]
5. JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer.
Danielpour D; Purighalla S; Wang E; Zmina PM; Sarkar A; Zhou G
Biochem Biophys Res Commun; 2019 Oct; 518(2):374-380. PubMed ID: 31434609
[TBL] [Abstract][Full Text] [Related]
6. The novel Jab1 inhibitor CSN5i-3 suppresses cell proliferation and induces apoptosis in human breast cancer cells.
Xiao H; Claret FX; Shen Q
Neoplasma; 2019 May; 66(3):481-486. PubMed ID: 30868895
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
[TBL] [Abstract][Full Text] [Related]
8. CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis.
Wan Z; Huang S; Mo F; Yao Y; Liu G; Han Z; Chen M; Zhiyun L
Exp Cell Res; 2019 Nov; 384(2):111646. PubMed ID: 31560888
[TBL] [Abstract][Full Text] [Related]
9. The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer.
Guo Z; Wang Y; Zhao Y; Shu Y; Liu Z; Zhou H; Wang H; Zhang W
Gene; 2019 Mar; 687():219-227. PubMed ID: 30468907
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53.
Lee EW; Oh W; Song HP; Kim WK
BMB Rep; 2017 Jul; 50(7):373-378. PubMed ID: 28539160
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of c-Jun activation domain-binding protein-1 in cancer: A systematic review and meta-analysis.
Shi D; Mu S; Hu B; Zhang S; Liu J; Zhang Z; Shao Z
J Cell Mol Med; 2021 Mar; 25(6):2750-2763. PubMed ID: 33550701
[TBL] [Abstract][Full Text] [Related]
12. A Novel Approach to Unraveling the Apoptotic Potential of Rutin (Bioflavonoid) via Targeting
Pandey P; Khan F; Alzahrani FA; Qari HA; Oves M
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577000
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional cofactor Jab1/Cops5 is crucial for BMP-mediated mouse chondrocyte differentiation by repressing p53 activity.
Mamidi MK; Samsa WE; Bashur LA; Chen Y; Chan R; Lee B; Zhou G
J Cell Physiol; 2021 Aug; 236(8):5686-5697. PubMed ID: 33393086
[TBL] [Abstract][Full Text] [Related]
14. Jab1-siRNA Induces Cell Growth Inhibition and Cell Cycle Arrest in Gall Bladder Cancer Cells via Targeting Jab1 Signalosome.
Pandey P; Siddiqui MH; Behari A; Kapoor VK; Mishra K; Sayyed U; Tiwari RK; Shekh R; Bajpai P
Anticancer Agents Med Chem; 2019; 19(16):2019-2033. PubMed ID: 31345154
[TBL] [Abstract][Full Text] [Related]
15. Jab1 has negative effects on p53-mediated genotoxic stresses.
Lee EW; Lee S; Song J
BMB Rep; 2009 May; 42(5):299-303. PubMed ID: 19470245
[TBL] [Abstract][Full Text] [Related]
16. Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5.
Wei Y; Liu G; Wu B; Yuan Y; Pan Y
Cell Physiol Biochem; 2018; 47(5):2126-2135. PubMed ID: 29975923
[TBL] [Abstract][Full Text] [Related]
17. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways.
Pan Y; Zhang Q; Atsaves V; Yang H; Claret FX
Oncogene; 2013 May; 32(22):2756-66. PubMed ID: 22797071
[TBL] [Abstract][Full Text] [Related]
19. Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair.
Tian L; Peng G; Parant JM; Leventaki V; Drakos E; Zhang Q; Parker-Thornburg J; Shackleford TJ; Dai H; Lin SY; Lozano G; Rassidakis GZ; Claret FX
Oncogene; 2010 Nov; 29(46):6125-37. PubMed ID: 20802511
[TBL] [Abstract][Full Text] [Related]
20. S100A7, Jab1, and p27
Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]